Back to Newsroom

Auris Medical Provides Board of Directors Update

Zug, Switzerland, September 26, 2017 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced today the resignation of Antoine Papiernik as a member of the Board of Directors due to disagreement with the Board regarding the strategic direction of the Company. The Board of Directors took note of his decision with regret.
READ MORE…